International Journal of Drug Delivery Technology
Volume 14, Issue 1

In-vitro, In-vivo Study of Jatropha curcas Leaves Extract, and Preparation of a Nanoemulsion by a Low-energy/Solvent-free Method, In-silico Study of β-Sitosterol in Ulcerative Colitis

Gayathiri K, Chitra V*

Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India. 

Received: 15th June, 2023; Revised: 01st January, 2024; Accepted: 18th February, 2024; Available Online: 25th March, 2024

ABSTRACT

Introduction: Ulcerative colitis (UC) is characterized by recurring colon inflammation, leading to severe symptoms and decreased quality of life. Jatropha curcas, a traditional remedy for UC, particularly its active component β-sitosterol, is investigated here for its potential therapeutic benefits.

Methods: The study evaluated J. curcas leaf extract’s effects on RAW 264.7 cell lines in-vitro, demonstrating a significant reduction in IL-6 production and promising anti-UC properties. In-vivo experiments on BALB/C mice with DSS-induced colitis confirmed dose-dependent reductions in disease severity, colon tissue damage, and pro-inflammatory cytokine levels. Additionally, a solvent-free nanoemulsion of J. curcas leaf extract was developed, exhibiting enhanced stability, encapsulation efficiency, and sustained release of active components, offering a promising drug delivery strategy for UC therapy. This interdisciplinary research contributes valuable insights into the therapeutic potential of J. curcas leaf extract and its nanoemulsion for UC treatment. Molecular docking simulations suggest strong binding affinities between β-sitosterol and inflammatory mediators, shedding light on its anti-inflammatory mechanisms. Pharmacokinetic and toxicity profiling further support the development of J. curcas-based UC therapeutics, laying a solid foundation for future studies and clinical applications.

Keywords: Ulcerative colitis, Jatropha curcas, β-sitosterol, Nanoemulsion, Anti-inflammatory, Therapeutic, In-vitro, In-vivo,

Molecular docking, Drug delivery.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.38

How to cite this article: Gayathiri K, Chitra V. In-vitro, In-vivo Study of Jatropha curcas Leaves Extract, and Preparation of a Nanoemulsion by a Low-energy/Solvent-free Method, In-silico Study of β-sitosterol in Ulcerative Colitis. International Journal of Drug Delivery Technology. 2024;14(1):265-273.

REFERENCES

  1. Makkar S, Becker KH, Sporer F, Wink M. Studies on Nutritive Potential and Toxic Constituents of Different Provenances of Jatropha curcas. Journal of Agricultural and Food Chemistry. 1997 Aug 18;45(8):3152–7.
  2. Assessment UENC for E. Antioxidant, anti-inflammatory and anticancer activities of methanolic extracts from Jatropha curcas Linn [Internet]. hero.epa.gov. 2009 [cited 2024 Mar 27]. Available from: https://hero.epa.gov/hero/index.cfm/reference/details/ reference_id/1560835
  3. Devappa RK, Makkar HP, Becker Biodegradation of Jatropha curcas phorbol esters in soil. Journal of the Science of Food and Agriculture. 2010 Jul 14;n/a-n/a.
  4. Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, et Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proceedings of the National Academy of Sciences. 2018 Mar 12;115(13):E2960–9.
  5. Che Z, Ye Z, Zhang X, Lin B, Yang W, Liang Y, et al. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases. Frontiers in Immunology. 2022 Aug 4;13.
  6. Martinez KB, Leone V, Chang EB. Microbial metabolites in health and disease: Navigating the unknown in search of Journal of Biological Chemistry [Internet]. 2017 Apr 7 [cited 2019 Nov 8];292(21):8553–9. Available from: http://www.jbc. org/content/292/21/8553.full
  7. Meisel M, et al. (2017) Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis. ISME J 11:15–30.
  8. Yan F, Polk DB. Probiotics and Probiotic-Derived Functional Factors—Mechanistic Insights Into Applications for Intestinal Homeostasis. Frontiers in Immunology. 2020 Jul 3;11.
  9. Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World Journal of Gastroenterology : WJG [Internet]. 2008 Jul 7 [cited 2020 Apr 16];14(25):3937–47. Available from: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC2725331/
  10. Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, et Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proceedings of the National Academy of Sciences. 2018 Mar 12;115(13):E2960–9.
  11. Snur Ma Hassan, Ali Hussein Hassan. The possibility of using shogaol for treatment of ulcerative colitis. PubMed. 2018 Sep 1;21(9):943–9.
  12. Shinde P B, “Component Screening of Miconazole Nitrate Nanoemulsion”, Asian Journal of Biomedical and Pharmaceutical Sciences, 2013, 3(19): 33-40.
  13. Ravi Shankar, Vishnu Tiwari “Formulation and Evaluation of Ketoconazole Nanoemulsion Gel for Topical Delivery”, American Journal of PharmTech Research, 2015, 5(5): 445-462.
  14. Jatin G, Praveen K, “Emerging trends in nanoemulsion design and therapeutics: a review”, Asian Journal of Pharmaceutical Sciences and Clinical Research, 2014, 2: 1-16.
  15. Kavitha K, Kanagathara N, “Optimization and solubilisation study of novel nanoemulsion formulation for 5-fluorouracil by applying pseudoternary phase diagram”, Asian Journal of Pharmaceutical and Clinical Research, 2014, 7(2): 137-139.
  16. Chandira R M, Pradeep, Pasupathi A, Bhowmik D, Chiranjib,Jayakar B, Tripathi K K and Sampath Kumar K P, “Design, Development and Formulation of Antiacne Dermatological Gel”, Journal of Chemical and Pharmaceutical Research, 2010, 2(1): 401-414.
  17. Dash S, Murthy P N, Nath L and Chowdhury P, “Kinetic modeling on drug release from controlled drug delivery systems”, Acta Poloniae Pharmaceutica - Drug Research, 2010, 67(3): 217-223.
  18. Siva Kumar B, Anuragh S, Kammala AK & Ilango K, Computer aided drug design approach to screen phytoconstituents of Adhatoda vasica as potential inhibitors of SARS-CoV-2 main protease enzyme. Life, 12 (2022) 315.
  19. Thakur S, Molecular docking analysis of phytoconstituents of Illicium verum fruit against Caspase 3, MMP-9 and TNFα. Indian J Biochem Biophys, 58 (2021) 510.
  20. Choudhury M, Sharma D, Das M & Dutta K, Molecular docking studies of natural and synthetic compounds against human secretory PLA2 in therapeutic intervention of inflammatory diseases and analysis of their pharmacokinetic Indian J Biochem Biophys, 59 (2022) 33.
  21. Ganeshpurkar A, Chaturvedi A, Shrivastava A, Dubey N, Jain S, Saxena N, Gupta P & Mujariya R, In-silico interaction of Berberine with some immunomodulatory targets: A docking Indian J Biochem Biophys, 59;2022:848
  22. Khan T, Dixit S, Ahmad R, Raza S, Azad I, Joshi S, et al. Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes. J Chem Biol. 2017 Jul;10(3):91–104.
  23. Lagunin A, Stepanchikova A, Filimonov D, Poroikov PASS: Prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16(8):747–8.
  24. Daina A, Michielin O, Zoete SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(October 2016):1–13.
  25. Ranjith D and Ravikumar C. SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Ipomoea mauritiana Jacq. ~ 2063 ~ J Pharmacogn Phytochem [Internet]. 2019;8(5):2063–73. Available from: http://www.swissadme.ch/index.php
  26. Rajkumar Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. The Lancet. 2013 Aug 10;396(10245):802–4.